RBC Capital raised the firm’s price target on Leidos (LDOS) to $230 from $210 and keeps an Outperform rating on the shares. The company’s earnings topped estimates, driven by continued strength in Health & Civil margins, the analyst tells investors in a research note. RBC adds that Leidos’s 1.3x book-to-bill and $69B near-term pipeline is robust, though the ongoing shutdown contributed to a more conservative 2025 guidance raise.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LDOS:
- Leidos price target raised to $216 from $209 at UBS
- Leidos Holdings Inc. Reports Robust Q3 Earnings
- Leidos Holdings Inc. Reports Strong Earnings Amid Challenges
- Leidos price target raised to $220 from $200 at Truist
- Leidos Holdings: Hold Rating Amid Strong Q3 Results and Government-Related Challenges